Showing 71-80 of 96 results for "".
- New Data Demonstrates Long-Term Safety, Efficacy of Galderma’s RelabotulinumtoxinAhttps://modernaesthetics.com/news/new-data-demonstrates-long-term-safety-efficacy-of-galdermas-relabotulinumtoxina/2473698/Galderma presented new phase III data from the READY-4 clinical trial at the American Society for Dermatologic Surgery (ASDS) 2024 Annual Meeting last week. The data demonstrates the long-term safety of RelabotulinumtoxinA (RelfydessTM) for frown lines and crow’s feet after repea
- Galderma Announces the Start of Six New Aesthetic Studieshttps://modernaesthetics.com/news/galderma-announces-the-start-of-six-new-aesthetic-studies/2472014/Galderma Laboratories, L.P. is initiating six new Phase III and IV U.S. aesthetic clinical trials. The six newly initiated studies include three pivotal trials evaluating XpresHAn Technology products; two studies for Dysport evaluating patient satisfaction and
- Syneron Candela's Profound SubQ FDA Approved to Improve Cellulitehttps://modernaesthetics.com/news/syneron-candelas-profound-subq-fda-approved-to-improve-cellulite/2472321/Syneron Candela received FDA 510(k) clearance for Profound when using the SubQ handpiece and cartridge to improve the appearance of cellulite in patients with Fitzpatrick skin types I-III, as supported by long term data (6 months). A recent multi-center clinical study of Profound sh
- Study Finds Abdominoplasty Can Help Improve Urinary Incontinence Symptomshttps://modernaesthetics.com/news/study-finds-abdominoplasty-can-help-improve-urinary-incontinence-symptoms/2483374/A new study published in Aesthetic Plastic Surgery reports that abdominoplasty may contribute to improvement in urinary incontinence symptoms. The study titled “Can Abdominoplasty Relieve Symptoms of Urinary Incontinence?” systematically reviewed the existing literature to evaluate the f
- CARE Curriculum Launched by DREAM Initiative from Allergan Aesthetics, SkinBetter Sciencehttps://modernaesthetics.com/news/care-curriculum-launched-by-dream-initiative-from-allergan-aesthetics-skinbetter-science/2473296/The DREAM Initiative®, developed by Allergan Aesthetics and skinbetter science®, has supported the development of a racial equity curriculum for dermatology residency programs. The Curriculum f
- ISAPS 2017: US Still Reigns As Cosmetic Surgery Capitol of the Worldhttps://modernaesthetics.com/news/isaps-2017-us-still-reigns-as-cosmetic-surgery-capitol-of-the-world/2471994/The USA, Brazil, Japan, Italy and Mexico continue to perform the most cosmetic surgery procedures across the globe, according to the 2017 statistics from the International Society of Aesthetic Plastic Surgery (ISAPS). These top five countries account f
- Newsweek OpEd: Senator, Modern Aesthetics® Magazine Contributor Address "No Surprises Act"https://modernaesthetics.com/news/newsweek-oped-senator-modern-aesthetics-magazine-contributor-address-no-surprises-act/2473207/Although surprise bills are one of the biggest drivers of medical bankruptcy in America, the "No Surprises Act" (NSA) is being overlooked, say Jonathan Kaplan, MD and Sen. William Cassidy, MD (R, Louisiana) in a new
- Expert Panel Recommends Diversity-Informed Standards for Facial Aesthetic Assessmenthttps://modernaesthetics.com/news/expert-panel-recommends-diversity-informed-standards-for-facial-aesthetic-assessment/2484691/A multidisciplinary panel of dermatologic and aesthetic experts led by American Society for Dermatologic Surgery (ASDS) president Kavita Mariwalla, MD, is calling for a shift away from Western-centric beauty norms toward more culturally inclusive, patient-centric f
- Skinbetter Science Launching New Face and Neck Treatment Creamhttps://modernaesthetics.com/news/skinbetter-science-launching-new-face-and-neck-cream/2473736/Skinbetter Science announced the launch of a new product on Wednesday. The InterFuse Treatment Cream FACE & NECK (F&N)’s aims to improve the appearance of sagging skin and wrinkles for visibly firmer, younger-looking skin through the use of a proprietary blend of collagen and elastin-supp
- First, Only US Neurotoxin for Simultaneous Treatment of Upper Facial Lines Gets FDA Approvalhttps://modernaesthetics.com/news/first-only-us-neurotoxin-for-simultaneous-treatment-of-upper-facial-lines-gets-fda-approval/2473638/Merz Aesthetics announced the US Food and Drug Administration approved XEOMIN (incobotulinumtoxinA) as the first and only neurotoxin for the simultaneous treatment of upper facial lines – forehead lines, frown lines, and crow’s feet. XEOMIN was first approved in 2011 f